NASDAQ$GSIT

Gsi Technology Inc · Q1 2026 earnings

Q1 2026 earnings · · After market close · Investor relations

Briefing

GSI Technology reported Q1 2026 revenue of $6.3M, a net loss of $2.2M, diluted EPS of $-0.05.

For Q1 2026, GSI Technology reported Revenue was $6.3M, net loss was $2.2M, diluted EPS was $-0.05. Management discusses segment trends, liquidity, and outlook in the quarterly filing.

  • Revenue $6.3M for Q1 2026.
  • Net loss $2.2M.
  • Diluted EPS $-0.05.

Headline financials

Total Revenue

$6.28M

Previous: $4.67M+34.5%
EPS (adj)

-$0.05

Previous: $0.04-225.0%
Total Operating Expenses

$5.83M

Previous: $6.82M-14.5%
Research & Development Expenses

$3.1M

Previous: $4.21M-26.5%
Selling, General & Administrative Expenses

$2.73M

Previous: $2.6M+4.8%
Interest and Other Income, Net

$13K

Previous: $55K-76.4%
Provision for Income Taxes

$54K

Previous: $57K-5.3%
Stock-based compensation

$341K

Previous: $658K-48.2%
Working capital

$25.7M

No prior period
Stockholders' equity

$37.4M

No prior period
Gross Margin

58.1%

Previous: 46.3%+25.5%
Capital Expenditures

-$21K

Previous: -$32K+34.4%
Free Cash Flow

-$1.73M

Previous: -$4.3M+59.7%
Net Income

-$2.22M

Previous: $1.08M-305.7%
Operating Income

-$2.18M

Previous: $1.08M-301.5%
Gross Profit

$3.65M

Previous: $2.16M+68.9%

Revenue & EPS history

Gsi Technology · Revenue · Quarterly

$6.28M

Q1 2026+34.5%vs Q1 2025
Beat estimate in 1 of 4 quarters(25%)
ActualEstimate

Revenue by segment

Gsi Technology · $6.35M total across 3 segments · Q4 2026

  • Military/defense
    $2.89M
  • SigmaQuad
    $2.06M
  • KYEC
    $1.4M

Forward guidance

Biotech and growth outlook emphasize pipeline milestones, partnerships, and path to profitability.

Tailwinds

  • Collaboration economics and product launches when applicable.
  • Cost discipline and cash runway.

Headwinds

  • Clinical, regulatory, and funding risk.
  • Operating losses until commercial scale.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2026

Historical avgQ1 2026

-2.7%

Avg return

Earnings day

-2.5%

Avg return

5 days after

-2.4%

Avg return

30 days after

35%

23 / 65 earnings

Positive

+21.6%

Q2 2013

Best reaction

-24.7%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026+9.7%+50.9%-1.6%
Q3 2026-5.8%-13.5%+8.2%
Q2 2026-4.9%-24.6%-47.8%
Q1 2026-13.4%-19.5%-32.4%
Q4 2025+5.1%+10.8%-0.3%
Q3 2025-0.4%+7.1%+1.8%
Q2 2025+1.5%+4.2%-4.5%
Q1 2025-14.2%-16.6%-20.5%
Q4 2024-24.7%-20.6%-33.8%
Q3 2024-17.2%-12.8%+6.6%
Q2 2024-19.9%-19.9%-6.5%
Q1 2024-9.3%-11.7%-33.0%
Q4 2023-18.4%+12.4%+71.9%
Q3 2023-0.5%+3.0%-12.6%
Q2 2023-8.7%-9.2%+2.4%
Q1 2023+0.5%-2.4%-14.3%
Q4 2022-6.9%-10.1%+4.5%
Q3 2022-4.1%+3.7%-8.4%
Q2 2022-1.3%+7.6%+7.4%
Q1 2022+6.2%+3.1%+12.4%
Q4 2021+2.3%+1.6%+5.4%
Q3 2021-1.0%+1.8%+1.2%
Q2 2021-2.9%-7.0%+8.9%
Q1 2021-11.2%+1.2%+1.7%
Q4 2020+7.0%+0.6%+4.3%
Q3 2020-0.7%-3.7%-18.5%
Q2 2020+0.9%+0.9%-4.3%
Q1 2020-6.5%-8.5%-8.3%
Q4 2019+0.2%-3.8%+2.6%
Q3 2019+0.1%+0.3%+5.2%
Q2 2019-0.8%-0.8%-6.0%
Q1 2019-0.7%-3.8%-6.6%
Q4 2018+2.6%+6.1%+3.5%
Q3 2018-6.6%-7.8%-8.9%
Q2 2018-0.9%+0.1%+22.1%
Q1 2018-9.3%-8.5%-20.1%
Q4 2017-0.5%-2.6%+10.9%
Q3 2017+0.2%-3.6%+8.8%
Q2 2017+1.5%-1.9%+5.6%
Q1 2017-5.1%-4.1%-4.5%
Q4 2016+0.3%
Q3 2016-2.8%
Q2 2016-0.7%
Q1 2016+3.2%
Q4 2015-0.6%
Q3 2015+1.3%
Q2 2015-2.9%
Q1 2015-0.8%
Q4 2014-5.8%
Q3 2014-1.2%
Q2 2014-5.9%
Q1 2014+5.5%
Q4 2013+0.3%
Q3 2013+3.2%
Q2 2013+21.6%
Q1 2013+2.1%
Q4 2012+2.4%
Q4 2010+2.4%
Q3 2011-0.6%
Q3 2012-0.6%
Q2 2011-2.2%
Q2 2012-2.2%
Q1 2012-10.5%
Q4 2011-10.5%
Q1 2011-10.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro